Zobrazeno 1 - 7
of 7
pro vyhledávání: '"392"'
Autor:
Shen-Hsun Lee, Yu-Chih Lin, Chih-Hsiang Chang, Yuhan Chang, I-Jung Chen, Pang-Hsin Hsieh, Chee-Jen Chang, Yi-Chun Wang
Publikováno v:
Thrombosis Research. 172:120-127
This study evaluated the incidence of symptomatic pulmonary embolism (PE), subsequent mortality, risk factors, and the effects of pharmacological thromboprophylactic intervention following hip fracture surgery in Taiwan.A nationwide study was conduct
Autor:
Michael Jaglal, Manila Gaddh, Tzu-Fei Wang, Damon E. Houghton, Pippa Simpson, Henny H. Billett, Lisa Baumann Kreuziger, Radhika Gali, Gemlyn George, Oluwatomiloba Onadeko, Mingen Feng, Thein Hlaing Oo, Michael B. Streiff
Publikováno v:
Thrombosis research. 202
Introduction Optimal treatment of catheter-related thrombosis (CRT) is uncertain in patients with hematologic malignancy. We aimed to evaluate the treatment strategies, outcomes, and predictors of recurrent venous thromboembolism (VTE) associated wit
Autor:
Helene Häberle, Stefanie Hammer, Reimer Riessen, Stefanie Nowak-Harnau, Peter Rosenberger, Karina Althaus, Sigrid Enkel, Andreas Straub, Oleg Hidiatov, Tamam Bakchoul
Publikováno v:
Thrombosis research. 188
Background Heparin-induced thrombocytopenia (HIT) is a serious drug induced reaction that may be associated with life threatening complications. Platelet-activating antibodies directed against platelet factor 4 (PF4)/heparin complexes cause the disea
Autor:
Pierre-Yves Le Roux, Christian Lavigne, Grégoire Le Gal, Philippe Robin, Adel Merah, Jean Pastre, Cécile Tromeur, Francis Couturaud, Pierre-Yves Salaun, Benjamin Planquette, Nathalie Prevot-Bitot
Publikováno v:
Thrombosis Research
Thrombosis Research, Elsevier, 2017, 159, pp.48-51
Thrombosis Research, Elsevier, 2017, 159, pp.48-51
Venous thromboembolism (VTE) can occur as the first manifestation of an underlying occult malignancy. It remains unclear whether or not a better selection of high risk patients might lead to more efficient occult cancer screening strategies. Our aim
Publikováno v:
Thrombosis Research. 75:293-305
Recombinant forms of human antithrombin (AT) were expressed in COS-1 cells, and their interaction with human thrombin characterized by comparing the reactivity of two engineered mutant forms of AT with the wild-type recombinant. Both mutant forms con
Autor:
Kazuhisa Kodama, Ayaka Murakami, Yasunori Ueda, Mayu Nishio, Mitsutoshi Asai, Akio Hirata, Koshi Matsuo, Takayoshi Nemoto, Kazunori Kashiwase
Publikováno v:
Thrombosis research. 129(2)
Yellow plaques are regarded vulnerable; and disrupted yellow plaques are the major cause of acute coronary syndrome. We examined the factors associated with the disruption of yellow plaques among patients and lesion characteristics.Consecutive 161 pa
Publikováno v:
Thrombosis research. 100(5)
We measured protein S (PS) activity in a large group of Japanese subjects to study the frequency of PS deficiency. The study group comprised 213 men, ages 18-58 years, and 179 women, ages 18-60 years. PS activity in the total 392 subjects was 58-135%